Company Filing History:
Years Active: 2011
Title: The Innovations of David Surguladze
Introduction: David Surguladze is an accomplished inventor based in Chatham, NJ, known for his significant contributions to the field of biotechnology. He has developed innovative solutions that address critical medical challenges, particularly in the treatment of leukemia.
Latest Patents: David Surguladze holds a patent for Anti-FLT3 antibodies. This invention provides fully human antibodies that specifically bind to human FLT3 within extracellular domains 4 or 5 with high affinity. The invention further outlines methods of treating leukemia by administering an effective amount of an antibody either alone or in combination with an anti-cancer agent or treatment, including methotrexate.
Career Highlights: Throughout his career, David has demonstrated a commitment to advancing medical science through his research and inventions. His work has the potential to improve treatment outcomes for patients suffering from leukemia, showcasing his dedication to innovation in healthcare.
Collaborations: David has collaborated with notable colleagues, including Yiwen Li and Dan Lu, who have contributed to his research efforts and the development of his patented technologies.
Conclusion: David Surguladze's innovative work in developing Anti-FLT3 antibodies exemplifies the impact of dedicated inventors in the field of biotechnology. His contributions are paving the way for new treatment options in leukemia, highlighting the importance of innovation in medicine.